Shiri Meshner

Company: Biomica Ltd.

Job title: VP R&D

Seminars:

Addressing Patient Recruitment Challenges in Microbiome Drug Development: Approach from Ongoing Phase I Trial of BMC128 in Combination with Nivolumab 11:30 am

Defining patient populations to support the investigation of safety and tolerability of BMC128 in combination with nivolumab, an anti-PD1 immune checkpoint inhibitor, in patients with non-small cell lung cancer (NSCLC), melanoma, or renal cell carcinoma (RCC) Patient identification processes, supporting preliminary findings of positive evidence of cancer therapies leveraging gut microbiota Additional update on preclinical…Read more

day: Conference Day One

Panel Discussion: Establishing Standards in Microbiome Clinical Studies to Enable Confidence in Comparable Data 12:00 pm

Uncover perspectives on the challenges in ensuring clinical data reproducibility, including the evaluation of current methods and studies to data Where does the industry see opportunities to harmonise study designs and protocols to support data interpretation? Learn areas of industry progression and opportunities for collaborative efforts to standardise methodologiesRead more

day: Conference Day One